Advisory Committee on the Safety of Medicines
The Advisory Committee on the Safety of Medicines (ACSOM) was established in January 2010 to advise and make recommendations to the TGA on the safety, risk assessment, and risk management of medicines. The ACSOM may also provide advice to the TGA on other matters relating to the detection, assessment, understanding, and prevention of adverse effects (known as pharmacovigilance), and any other matters referred to it by the TGA. The ACSOM supersedes and expands upon the role of the Adverse Drug Reactions Advisory Committee, with an increased focus on the safety aspects of medicine regulation and the detection, assessment, understanding, and prevention of adverse effects.
Type of Body
E. Statutory Office Holder Offices and Committees
Established By / Under
Act / Regulation
Established By/Under More info
Therapeutic Goods Regulations 1990
Max No. of Board/Committee Members
Annual Report Prepared and tabled?
1 January 2010